中文名 | 他索沙坦 |
英文名 | Tasosartan |
别名 | 塔索萨坦 他索沙坦 他沙索坦 2,4-二甲基-8-[[4-[2-(2H-四唑-5-基)苯基]苯基]甲基]-5,6-二氢吡啶并[6,5-D]嘧啶-7-酮 8-((2'-(1H-四唑-5-基)-[1,1'-联苯] -4-基)甲基)-2,4-二甲基-5,6-二氢吡啶并[2,3-D ]嘧啶-7(8H) - 酮 |
英文别名 | ANA-756 DB01349 AC1L1U5X AC1Q6LAA TASOSARTAN Tasosartan S1539_Selleck 2,4-Dimethyl-8-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-5,6-dihydropyrido[6,5-d]pyrimidin-7-one 5,8-Dihydro-2,4-dimethyl-8-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]pyrido[2,3-d]pyrimidin-7(6H)-one |
CAS | 145733-36-4 |
化学式 | C23H21N7O |
分子量 | 411.46 |
密度 | 1.328±0.06 g/cm3(Predicted) |
熔点 | 197-199° |
沸点 | 759.4±70.0 °C(Predicted) |
溶解度 | DMSO (微溶),甲醇 (微溶,超声处理) |
酸度系数 | 4.16±0.10(Predicted) |
存储条件 | 2-8°C |
外观 | 固体 |
颜色 | White to Off-White |
体外研究 | Tasosartan is an orally active nonpeptide AngII antagonist that has demonstrates specific and selective AT1 receptor antagonistic activity in vitro. IC 50 for inhibition of specific binding of 125 I-AngII to rat adrenal membrane in the absence of proteins in binding buffer is 1.2±0.6 nM. |
体内研究 | Administration of Tasosartan at doses of 1.0 and 3.0 mg/kg (iv) significantly (p<0.05) attenuates the pressor response to angiotensin-II in rats. |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!